Dr Lim Sheow Lei is a Senior Consultant Medical Oncologist at OncoCare Cancer Centre. Her clinical expertise includes the treatment of gynaecological cancers, such as cancers of the ovary, uterus, cervix, and vulva. She has more than 25 years of clinical experience. Dr Lim graduated with Honours from Monash University Medical School (Australia) in 1996. She received her medical oncology speciality training in the United Kingdom and trained under several renowned oncologists, including Prof Hani Gabra, a world-renowned expert on ovarian cancer. She obtained her certification in Medical Oncology from the United Kingdom Postgraduate Medical Education Training Board in 2008.
She was awarded an MD in Medical Science for her research conducted at the internationally renowned Institute of Cancer Research, London (ICR, United Kingdom), focusing on ovarian cancer epigenetics. Prior to joining OncoCare, Dr Lim was a Senior Consultant Medical Oncologist in the Department of Gynaecological Oncology at KK Women’s and Children’s Hospital (KKH), an Adjunct Associate Professor at Duke-NUS Medical School, and a Visiting Consultant at the National Cancer Centre, specialising in the treatment of gynaecological cancers (ovarian, uterine, cervical, and vulvar cancers). She was also the Head of the Chemotherapy Centre for Women’s Cancer at KK Women’s and Children’s Hospital.
She was the Chairperson of the Singapore Cancer Network (SCAN) Gynaecological Cancer Workgroup, which developed the first national consensus guidelines for the treatment of ovarian and uterine cancers in Singapore. Dr Lim is also a passionate educator. She was involved in teaching medical students from Duke-NUS Medical School and the National University of Singapore. She also served as the Programme Director at KK Women’s and Children’s Hospital for the Medical Oncology residency training programme in gynaecological cancers, training oncology trainees from the National Cancer Centre and Tan Tock Seng Hospital.
Aside from her clinical work and teaching, Dr Lim has been actively involved in cancer research. She has served as Principal Investigator for numerous clinical drug trials investigating novel treatments, including targeted therapies and immunotherapy, for gynaecological cancers. She was awarded research grants by the Japanese government for collaborative research with Japanese researchers, focusing on the role of intraperitoneal chemotherapy (injecting chemotherapy into the abdominopelvic cavity) in the treatment of advanced ovarian cancer.
Her research in gynaecological cancers has been widely published in both international and local peer-reviewed journals, including the British Journal of Cancer and The Oncologist. She has been invited to lecture, chair sessions, and speak at various local and international cancer conferences, including delivering oral presentations at the prestigious American Society of Clinical Oncology (ASCO) Annual Meeting. She continues to be actively involved in international clinical trials evaluating novel cancer therapies.
Dr Lim is fluent in English and Mandarin.
